Rowland & CO Investment Counsel Bio Techne Corp Transaction History

Rowland & CO Investment Counsel

  • $473 Million
  • Q2 2025

A detailed history of Rowland & CO Investment Counsel transactions in Bio Techne Corp stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 40,480 shares of TECH stock, worth $2.09 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
40,480
Previous 39,880 1.5%
Holding current value
$2.09 Million
Previous $2.34 Million 10.95%
% of portfolio
0.44%
Previous 0.5%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 01, 2025
BUY
$46.66 - $58.38 $27,995 - $35,028
600 Added 1.5%
40,480 $2.08 Million
Q1 2025

Apr 15, 2025
SELL
$58.47 - $78.75 $35,666 - $48,037
-610 Reduced 1.51%
39,880 $2.34 Million
Q4 2024

Feb 04, 2025
SELL
$66.37 - $78.17 $38,494 - $45,338
-580 Reduced 1.41%
40,490 $2.92 Million
Q2 2024

Jul 29, 2024
SELL
$62.12 - $84.15 $401,605 - $544,029
-6,465 Reduced 13.6%
41,070 $2.94 Million
Q1 2024

Apr 08, 2024
SELL
$65.98 - $77.09 $29,031 - $33,919
-440 Reduced 0.92%
47,535 $3.35 Million
Q4 2023

Jan 03, 2024
SELL
$52.83 - $78.22 $61,282 - $90,735
-1,160 Reduced 2.36%
47,975 $3.7 Million
Q2 2023

Aug 04, 2023
SELL
$73.76 - $85.98 $74,497 - $86,839
-1,010 Reduced 2.01%
49,135 $4.01 Million
Q1 2023

Apr 25, 2023
SELL
$71.62 - $86.62 $19,695 - $23,820
-275 Reduced 0.55%
50,145 $3.72 Million
Q4 2022

Jan 04, 2023
BUY
$80.67 - $352.29 $3.01 Million - $13.2 Million
37,350 Added 285.77%
50,420 $0
Q1 2022

Apr 26, 2022
SELL
$353.85 - $487.79 $298,649 - $411,694
-844 Reduced 6.07%
13,070 $5.66 Million
Q4 2021

Feb 14, 2022
SELL
$456.15 - $525.06 $1.13 Million - $1.31 Million
-2,488 Reduced 15.17%
13,914 $7.2 Million
Q3 2021

Nov 08, 2021
BUY
$444.87 - $538.88 $891,964 - $1.08 Million
2,005 Added 13.93%
16,402 $7.95 Million
Q2 2021

Aug 09, 2021
SELL
$387.35 - $450.26 $38,735 - $45,026
-100 Reduced 0.69%
14,397 $6.48 Million
Q1 2021

May 11, 2021
SELL
$314.62 - $411.0 $388,555 - $507,585
-1,235 Reduced 7.85%
14,497 $5.54 Million
Q4 2020

Feb 11, 2021
SELL
$246.9 - $321.87 $190,113 - $247,839
-770 Reduced 4.67%
15,732 $5 Million
Q3 2020

Nov 12, 2020
BUY
$232.22 - $282.96 $23,222 - $28,295
100 Added 0.61%
16,502 $4.09 Million
Q2 2020

Aug 10, 2020
SELL
$185.43 - $279.56 $18,543 - $27,956
-100 Reduced 0.61%
16,402 $4.33 Million
Q1 2020

May 11, 2020
SELL
$161.17 - $221.51 $112,818 - $155,057
-700 Reduced 4.07%
16,502 $3.13 Million
Q4 2019

Jan 28, 2020
BUY
$189.68 - $222.09 $75,872 - $88,836
400 Added 2.38%
17,202 $3.78 Million
Q3 2019

Oct 02, 2019
SELL
$183.56 - $216.72 $9,178 - $10,836
-50 Reduced 0.3%
16,802 $3.29 Million
Q2 2019

Jul 09, 2019
SELL
$188.72 - $215.43 $45,292 - $51,703
-240 Reduced 1.4%
16,852 $0
Q1 2019

Apr 10, 2019
SELL
$136.09 - $200.44 $4,490 - $6,614
-33 Reduced 0.19%
17,092 $0
Q4 2018

Feb 12, 2019
BUY
$132.75 - $203.8 $20,576 - $31,589
155 Added 0.91%
17,125 $2.48 Million
Q3 2018

Oct 22, 2018
SELL
$147.44 - $204.11 $92,150 - $127,568
-625 Reduced 3.55%
16,970 $0
Q2 2018

Jul 11, 2018
SELL
$144.9 - $165.58 $21,735 - $24,837
-150 Reduced 0.85%
17,595 $0
Q1 2018

Apr 17, 2018
SELL
$131.46 - $151.04 $292,498 - $336,064
-2,225 Reduced 11.14%
17,745 $0
Q4 2017

Jan 11, 2018
SELL
$121.17 - $134.75 $101,298 - $112,651
-836 Reduced 4.02%
19,970 $0
Q3 2017

Oct 11, 2017
SELL
$113.59 - $123.78 $124,267 - $135,415
-1,094 Reduced 5.0%
20,806 $0
Q3 2017

Oct 11, 2017
BUY
$113.59 - $123.78 $2.49 Million - $2.71 Million
21,900
21,900 $0

Others Institutions Holding TECH

# of Institutions
627
Shares Held
160M
Call Options Held
90K
Put Options Held
14.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.02B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Rowland & CO Investment Counsel Portfolio

Follow Rowland & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email